Speakers

Keith Luhrs

By Jackie Wengrod | November 20, 2025

Experienced drug discovery executive with successful track record leading teams across multiple sites to accomplish challenging goals. Background in biologics (Ig and alternative scaffolds), protein…

Read More

Bindu Manne

By Jackie Wengrod | November 20, 2025

Bindu Manne is a seasoned ophthalmic industry leader with over 20 years of experience driving innovation and growth across the eyecare ecosystem. Throughout her career,…

Read More

Tamir Meiri, MBA

By Jackie Wengrod | November 20, 2025

With over a decade of experience in venture capital investment, Tamir is responsible for identifying and leading medical device, consumer and health technology investments in…

Read More

Ronil Patel, MSc

By Jackie Wengrod | November 20, 2025

Mr. Ronil Patel currently serves as Chief Business Officer at RevOpsis Therapeutics. Mr. Patel has over 15 years of experience in medical research, including biotech…

Read More

John Sholar, JD

By Jackie Wengrod | November 20, 2025

John is a seasoned biotech executive, having served at various times over the years as jCyte’s General Counsel and Corporate Secretary, Chief Strategy Officer, Chief…

Read More

Dawn Koffler

By Jackie Wengrod | November 20, 2025

Dawn Koffler is the Chief Business Officer at Osanni Bio, where she leads corporate strategy and business operations. She brings more than 20 years of…

Read More

Peter Michael Benz, PhD

By Jackie Wengrod | November 20, 2025

Peter Benz is the Head of Strategic Partnering for Eye Health at Boehringer Ingelheim, where he leads efforts to access external innovative solutions for retinal…

Read More

Leanne Labriola, DO, MBA

By Jackie Wengrod | November 20, 2025

Leanne Labriola is a board-certified ophthalmologist as well as serial entrepreneur. Her past training includes undergraduate at Duke University, medicine training at the Philadelphia College…

Read More

Richard “Rick” L. Beckman, MD

By Jackie Wengrod | November 20, 2025

Rick Beckman, M.D, is the Principal at RLB, MD Consulting, LLC where he provides expertise gained from more than 13 years in clinical practice and…

Read More

Jeff Franco

By Jackie Wengrod | November 10, 2025

Jeffrey Franco is the Chief Executive Officer of OcuDyne, Inc., a clinical-stage ophthalmology company focused on novel perfusion-based approaches to geographic atrophy and other retinal…

Read More

Luke Zack

By Jackie Wengrod | November 10, 2025

Luke Zack, PharmD, is the Senior Director and Global Head of Regulatory Affairs Strategy at Oculis US, Inc., a global biopharmaceutical company pioneering innovative treatments…

Read More

Warren Dunnavant

By Jackie Wengrod | November 10, 2025

Mr. Dunnavant is a Managing Director at H.C. Wainwright & Co., where he leads healthcare investment banking efforts in the life sciences sector. He brings…

Read More

SUBSCRIBE TO OIS NEWS

Get Our Weekly Newsletter About The Latest In Ophthalmic Innovation.

We respect your privacy and promise to never send you spam.

Something went wrong. Please check your entries and try again.